The Global Insulin Market is expected to reach USD 42 billion by 2020, growing at a CAGR of XX%. Insulin is a peptide hormone secreted by the beta cells in the pancreas. Insulin maintains the metabolism of carbohydrates and fats by enhancing storage of fat instead of usage for energy.
Download The Sample Copy Of This Report @ http://orianresearch.com/request-sample/Global-Insulin-Market-Industry-Analysis-and-forecast-2017-2022
Insulin is externally administered to patients suffering from diabetes mellitus, which is a metabolic disorder where the body is unable to maintain its blood glucose level.
Global Insulin Market- Market Dynamics
According to WHO, 1.5 million deaths in 2012 and 89 million DALYs were directly due to diabetes. WHO also estimated the global prevalence of diabetes to be 9% in 2014. According to the International Diabetes Federation, the global prevalence of diabetes was 366 million in 2011. This depicts a large patient population worldwide. Insulin had a market size at USD 24 billion in 2014.
Complete Report Available at: http://orianresearch.com/report/global-insulin-market-industry-analysis-and-forecast-2017-2022
- Some of the factors driving the global insulin market are:
- Rising diabetes patient population
- Increasing lifestyle disorder
Some of the key players in the market are:
- Dongbao Enterprises Group Co. Ltd.
- Merck & Co.
What the Report Offers
Market definition for the Global Insulin Market along with identification of key drivers and restraints for the market.
Market analysis for the insulin market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Know More With TOC Of This Report –
Table of Contents
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
- Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
- Executive Summary
- Key Inferences
- Market Overview and Industry trends
5.1 Current Market Scenario
5.2 Insulin Applications
5.3 Technology Overview
5.4 New Developments
5.5 Industry Value chain analysis
- Drivers, Restraints, Opportunities, Analysis
6.1 Market Drivers
6.1.1 Rising Diabetes patient population
6.1.2 Increasing lifestyle disorders
6.1.3 Government initiatives
6.1.4 Biologics going off-patent
6.1.5 Increasing demand for insulin analogs
6.2 Market Restraints
6.2.1 Stringent regulatory requirement
6.2.2 High cost of Production
6.3 Market Opportunities
- Global Insulin Market segmentation
7.2 Modern Insulin
7.2.1 Rapid-acting insulin
7.2.2 Long-Acting Insulin
7.2.3 Premixed modern Insulin
7.3 Traditional insulin
Orian Research is one of the most comprehensive collection of market intelligence reports on
the World Wide Web. Our reports repository boasts of over 500000+ industry and country
research reports from over 100 top publishers. We continuously update our repository so as to
provide our clients easy access to the world’s most complete and current database of expert
insights on global industries, companies, and products.
Vice President – Global Sales
+1 (832) 380-8827